Role of hemodynamic active drugs, differential effects of drug families (Dirk von Lewinski, Graz, Austria)

There are plenty of options to interact with haemodynamics and inotropy and many studies have explored this in order to find a solution to overcome the challenges of AHF. Professor von Lewinski presents relevant data and succinctly points out why specific treatment options do not work or can’t currently be used in clinical practice. For now, the treatment focus should be on the calcium sensitiser levosimendan, a best-in-class inotrope.

 

Videos (5)
Login/ Register Maximise Minimise